# Badger Meter Inc: financial statements, quarterly BMI · NYSE · CIK 9092 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bmi.md) · [Financials](/companies/bmi/financials.md) · [Filings](/companies/bmi/filings.md) · [Insiders](/companies/bmi/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bmi/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [182](/filings/0000950170-25-020889.md) | [196](/filings/0001193125-26-054739.md) | [217](/filings/0001193125-26-054739.md) | [208](/filings/0001193125-26-054739.md) | [205](/filings/0001193125-26-054739.md) | [222](/filings/0001193125-26-163625.md) | [238](/filings/0001193125-26-313981.md) | [236](/filings/0001193125-26-430469.md) | [221](/filings/0001193125-26-054739.md) | [202](/filings/0001193125-26-163625.md) | [222](/filings/0001193125-26-313981.md) | [236](/filings/0001193125-26-430469.md) | | Cost of revenue | $m | [111 d](/filings/0001193125-26-054739.md) | [119](/filings/0000950170-25-055763.md) | [131](/filings/0000950170-25-097847.md) | [125](/filings/0001193125-25-246630.md) | [122 d](/filings/0001193125-26-054739.md) | [127](/filings/0001193125-26-163625.md) | [140](/filings/0001193125-26-313981.md) | [140](/filings/0001193125-26-430469.md) | [128 d](/filings/0001193125-26-054739.md) | [118](/filings/0001193125-26-163625.md) | [132](/filings/0001193125-26-313981.md) | [137](/filings/0001193125-26-430469.md) | | Gross profit | $m | [71.5](/filings/0000950170-25-020889.md) | [77.2](/filings/0001193125-26-054739.md) | [85.4](/filings/0001193125-26-054739.md) | [83.9](/filings/0001193125-26-054739.md) | [82.8](/filings/0001193125-26-054739.md) | [95.4](/filings/0001193125-26-163625.md) | [97.8](/filings/0001193125-26-313981.md) | [95.8](/filings/0001193125-26-430469.md) | [93.0](/filings/0001193125-26-054739.md) | [84.3](/filings/0001193125-26-163625.md) | [90.8](/filings/0001193125-26-313981.md) | [98.8](/filings/0001193125-26-430469.md) | | Selling, general and administrative | $m | [39.4 d](/filings/0001193125-26-054739.md) | [40.6](/filings/0000950170-25-055763.md) | [43.9](/filings/0000950170-25-097847.md) | [43.3](/filings/0001193125-25-246630.md) | [43.5 d](/filings/0001193125-26-054739.md) | [46.0](/filings/0001193125-26-163625.md) | [52.9](/filings/0001193125-26-313981.md) | [49.8](/filings/0001193125-26-430469.md) | [49.9 d](/filings/0001193125-26-054739.md) | [49.2](/filings/0001193125-26-163625.md) | [51.4](/filings/0001193125-26-313981.md) | [51.1](/filings/0001193125-26-430469.md) | | Operating income | $m | [32.1 d](/filings/0001193125-26-054739.md) | [36.6](/filings/0000950170-25-055763.md) | [41.5](/filings/0000950170-25-097847.md) | [40.6](/filings/0001193125-25-246630.md) | [39.2 d](/filings/0001193125-26-054739.md) | [49.4](/filings/0001193125-26-163625.md) | [44.9](/filings/0001193125-26-313981.md) | [46.1](/filings/0001193125-26-430469.md) | [43.0 d](/filings/0001193125-26-054739.md) | [35.2](/filings/0001193125-26-163625.md) | [39.4](/filings/0001193125-26-313981.md) | [47.7](/filings/0001193125-26-430469.md) | | Income tax | $m | [8.7 d](/filings/0001193125-26-054739.md) | [9.0](/filings/0000950170-25-055763.md) | [10.3](/filings/0000950170-25-097847.md) | [10.9](/filings/0001193125-25-246630.md) | [11.4 d](/filings/0001193125-26-054739.md) | [12.4](/filings/0001193125-26-163625.md) | [11.2](/filings/0001193125-26-313981.md) | [12.4](/filings/0001193125-26-430469.md) | [11.1 d](/filings/0001193125-26-054739.md) | [9.0](/filings/0001193125-26-163625.md) | [10.0](/filings/0001193125-26-313981.md) | [12.1](/filings/0001193125-26-430469.md) | | Net income | $m | [24.7](/filings/0000950170-25-020889.md) | [29.1](/filings/0001193125-26-054739.md) | [33.1](/filings/0001193125-26-054739.md) | [32.0](/filings/0001193125-26-054739.md) | [30.7](/filings/0001193125-26-054739.md) | [38.4](/filings/0001193125-26-163625.md) | [34.6](/filings/0001193125-26-313981.md) | [35.1](/filings/0001193125-26-430469.md) | [33.6](/filings/0001193125-26-054739.md) | [27.3](/filings/0001193125-26-163625.md) | [29.7](/filings/0001193125-26-313981.md) | [35.9](/filings/0001193125-26-430469.md) | | Diluted EPS | $ per share | [0.84](/filings/0000950170-25-020889.md) | [0.99](/filings/0001193125-26-054739.md) | [1.12](/filings/0001193125-26-054739.md) | [1.08](/filings/0001193125-26-054739.md) | [1.04](/filings/0001193125-26-054739.md) | [1.30](/filings/0001193125-26-163625.md) | [1.17](/filings/0001193125-26-313981.md) | [1.19](/filings/0001193125-26-430469.md) | [1.14](/filings/0001193125-26-054739.md) | [0.93](/filings/0001193125-26-163625.md) | [1.02](/filings/0001193125-26-313981.md) | [1.24](/filings/0001193125-26-430469.md) | | Basic EPS | $ per share | [0.84](/filings/0000950170-25-020889.md) | [0.99](/filings/0001193125-26-054739.md) | [1.13](/filings/0001193125-26-054739.md) | [1.09](/filings/0001193125-26-054739.md) | [1.05](/filings/0001193125-26-054739.md) | [1.31](/filings/0001193125-26-163625.md) | [1.18](/filings/0001193125-26-313981.md) | [1.19](/filings/0001193125-26-430469.md) | [1.14](/filings/0001193125-26-054739.md) | [0.94](/filings/0001193125-26-163625.md) | [1.02](/filings/0001193125-26-313981.md) | [1.25](/filings/0001193125-26-430469.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [192](/filings/0000950170-25-020889.md) | [199](/filings/0000950170-24-045898.md) | [226](/filings/0000950170-24-085171.md) | [259](/filings/0000950170-24-115576.md) | [295](/filings/0001193125-26-054739.md) | [131](/filings/0000950170-25-055763.md) | [165](/filings/0000950170-25-097847.md) | [202](/filings/0001193125-25-246630.md) | [226](/filings/0001193125-26-430469.md) | [205](/filings/0001193125-26-163625.md) | [95.7](/filings/0001193125-26-313981.md) | [67.9](/filings/0001193125-26-430469.md) | | Current assets | $m | [442](/filings/0000950170-25-020889.md) | [471](/filings/0000950170-24-045898.md) | [509](/filings/0000950170-24-085171.md) | [529](/filings/0000950170-24-115576.md) | [540](/filings/0001193125-26-054739.md) | [412](/filings/0000950170-25-055763.md) | [448](/filings/0000950170-25-097847.md) | [495](/filings/0001193125-25-246630.md) | [507](/filings/0001193125-26-430469.md) | [508](/filings/0001193125-26-163625.md) | [416](/filings/0001193125-26-313981.md) | [368](/filings/0001193125-26-430469.md) | | Total assets | $m | [717](/filings/0000950170-25-020889.md) | [743](/filings/0000950170-24-045898.md) | [781](/filings/0000950170-24-085171.md) | [803](/filings/0000950170-24-115576.md) | [816](/filings/0001193125-26-054739.md) | [900](/filings/0000950170-25-055763.md) | [936](/filings/0000950170-25-097847.md) | [978](/filings/0001193125-25-246630.md) | [974](/filings/0001193125-26-430469.md) | [971](/filings/0001193125-26-163625.md) | [998](/filings/0001193125-26-313981.md) | [944](/filings/0001193125-26-430469.md) | | Current liabilities | $m | [132](/filings/0000950170-25-020889.md) | [135](/filings/0000950170-24-045898.md) | [138](/filings/0000950170-24-085171.md) | [129](/filings/0000950170-24-115576.md) | [118](/filings/0001193125-26-054739.md) | [141](/filings/0000950170-25-055763.md) | [139](/filings/0000950170-25-097847.md) | [153](/filings/0001193125-25-246630.md) | [151](/filings/0001193125-26-430469.md) | [169](/filings/0001193125-26-163625.md) | [172](/filings/0001193125-26-313981.md) | [148](/filings/0001193125-26-430469.md) | | Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | [0.0](/filings/0000950170-25-020889.md) | not reported | not reported | not reported | [0.0](/filings/0001193125-26-054739.md) | not reported | not reported | not reported | [0.0](/filings/0001193125-26-054739.md) | not reported | not reported | not reported | | Shareholders' equity | $m | [516](/filings/0001193125-26-054739.md) | [536](/filings/0000950170-25-097847.md) | [563](/filings/0001193125-25-246630.md) | [591](/filings/0001193125-25-246630.md) | [606](/filings/0001193125-26-430469.md) | [642](/filings/0001193125-26-313981.md) | [678](/filings/0001193125-26-430469.md) | [703](/filings/0001193125-26-430469.md) | [713](/filings/0001193125-26-430469.md) | [690](/filings/0001193125-26-313981.md) | [683](/filings/0001193125-26-430469.md) | [651](/filings/0001193125-26-430469.md) | - Cash and equivalents: us-gaap:Cash - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: not reported - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [37.9 d](/filings/0001193125-26-054739.md) | [21.5](/filings/0000950170-25-055763.md) | [36.4 d](/filings/0000950170-25-097847.md) | [45.1 d](/filings/0001193125-25-246630.md) | [52.1 d](/filings/0001193125-26-054739.md) | [33.0](/filings/0001193125-26-163625.md) | [44.6 d](/filings/0001193125-26-313981.md) | [51.3 d](/filings/0001193125-26-430469.md) | [54.8 d](/filings/0001193125-26-054739.md) | [33.9](/filings/0001193125-26-163625.md) | [26.7 d](/filings/0001193125-26-313981.md) | [43.3 d](/filings/0001193125-26-430469.md) | | Capital expenditure | $m | [2.1 d](/filings/0001193125-26-054739.md) | [2.7](/filings/0000950170-25-055763.md) | [2.3 d](/filings/0000950170-25-097847.md) | [3.1 d](/filings/0001193125-25-246630.md) | [4.7 d](/filings/0001193125-26-054739.md) | [3.0](/filings/0001193125-26-163625.md) | [3.9 d](/filings/0001193125-26-313981.md) | [3.1 d](/filings/0001193125-26-430469.md) | [4.0 d](/filings/0001193125-26-054739.md) | [4.4](/filings/0001193125-26-163625.md) | [4.8 d](/filings/0001193125-26-313981.md) | [3.0 d](/filings/0001193125-26-430469.md) | | Dividends paid | $m | [7.9 d](/filings/0001193125-26-054739.md) | [7.9](/filings/0000950170-25-055763.md) | [7.9 d](/filings/0000950170-25-097847.md) | [10.0 d](/filings/0001193125-25-246630.md) | [10.0 d](/filings/0001193125-26-054739.md) | [10.0](/filings/0001193125-26-163625.md) | [10.0 d](/filings/0001193125-26-313981.md) | [11.8 d](/filings/0001193125-26-430469.md) | [11.7 d](/filings/0001193125-26-054739.md) | [11.7](/filings/0001193125-26-163625.md) | [11.6 d](/filings/0001193125-26-313981.md) | [12.6 d](/filings/0001193125-26-430469.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-163625.md) | [0.0 d](/filings/0001193125-26-313981.md) | not reported | not reported | [38.2](/filings/0001193125-26-163625.md) | [25.3 d](/filings/0001193125-26-313981.md) | [55.5 d](/filings/0001193125-26-430469.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [29.4](/filings/0000950170-24-045898.md) | [29.4](/filings/0000950170-24-085171.md) | [29.5](/filings/0000950170-24-115576.md) | [29.5](/filings/0000950170-25-055763.md) | [29.5](/filings/0000950170-25-097847.md) | [29.5](/filings/0001193125-25-246630.md) | [29.6](/filings/0001193125-26-163625.md) | [29.6](/filings/0001193125-26-313981.md) | [29.6](/filings/0001193125-26-430469.md) | [29.4](/filings/0001193125-26-163625.md) | [29.1](/filings/0001193125-26-313981.md) | [28.9](/filings/0001193125-26-430469.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 28,563,652 at 2026-10-09, from the cover of the [10-Q filed 2026-10-23](/filings/0001193125-26-430469.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.